Issue 5/2012
Content (29 Articles)
Slugging their way to immortality: driving mammary epithelial cells into a stem cell-like state
Kelly Soady, Matthew J Smalley
Retinoids and breast cancer: new clues to increase their activity and selectivity
Enrico Garattini, Gabriela Paroni, Mineko Terao
New insights into signalling networks regulating breast cancer stem cells
Alexander Swarbrick, Roger J Daly
DNA damage as a result of psychological stress: implications for breast cancer
Melanie S Flint, Dana H Bovbjerg
Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?
Richard A Steinman, Adam M Brufsky, Steffi Oesterreich
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes
Muhammad Riaz, Anieta M Sieuwerts, Maxime P Look, Mieke A Timmermans, Marcel Smid, John A Foekens, John WM Martens
A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion
Meiou Dai, Amal A Al-Odaini, Ani Arakelian, Shafaat A Rabbani, Suhad Ali, Jean-Jacques Lebrun
Regulation of mRNA expression in breast cancer - a cis-tematic trans-action
Roel GW Verhaak, Gordon B Mills
Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug
Matteo Lazzeroni, Davide Serrano, Barbara K Dunn, Brandy M Heckman-Stoddard, Oukseub Lee, Seema Khan, Andrea Decensi
Who's driving anyway? Herculean efforts to identify the drivers of breast cancer
Ryan J Hartmaier, Nolan Priedigkeit, Adrian V Lee
Retraction Note: Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial
Akke Albada, Sandra van Dulmen, Jozien M Bensing, Margreet GEM Ausems
Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo
Lesley-Ann Martin, Sunil Pancholi, Ian Farmer, Stephanie Guest, Ricardo Ribas, Marion T Weigel, Allan M Thornhill, Zara Ghazoui, Roger A'Hern, Dean B Evans, Heidi A Lane, Stephen R Johnston, Mitch Dowsett
Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer
Christopher H Switzer, Robert Y-S Cheng, Lisa A Ridnour, Sharon A Glynn, Stefan Ambs, David A Wink
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study
Ines Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, P Kelly Marcom, Beverly Moy, Hope S Rugo, Richard L Theriault, John Wilson, Joyce C Niland, Jane C Weeks, Nancy U Lin
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes
Amy R Peck, Agnieszka K Witkiewicz, Chengbao Liu, Alexander C Klimowicz, Ginger A Stringer, Edward Pequignot, Boris Freydin, Ning Yang, Adam Ertel, Thai H Tran, Melanie A Girondo, Anne L Rosenberg, Jeffrey A Hooke, Albert J Kovatich, Craig D Shriver, David L Rimm, Anthony M Magliocco, Terry Hyslop, Hallgeir Rui
Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion
Nicola Aceto, Stephan Duss, Gwen MacDonald, Dominique S Meyer, Tim-C Roloff, Nancy E Hynes, Mohamed Bentires-Alj
Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users
Merete Ellingjord-Dale, Eunjung Lee, Elisabeth Couto, Ali Ozhand, Samera Azeem Qureshi, Solveig Hofvind, David J Van Den Berg, Lars A Akslen, Tom Grotmol, Giske Ursin
Breast vibro-acoustography: initial results show promise
Azra Alizad, Dana H Whaley, Matthew W Urban, Rickey E Carter, Randall R Kinnick, James F Greenleaf, Mostafa Fatemi
Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer
Yoshimasa Kosaka, Akemi Kataoka, Hiroshi Yamaguchi, Hiroaki Ueo, Sayuri Akiyoshi, Norihiko Sengoku, Masaru Kuranami, Shinji Ohno, Masahiko Watanabe, Koshi Mimori, Masaki Mori
Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients
Antonia Patsialou, Yarong Wang, Juan Lin, Kathleen Whitney, Sumanta Goswami, Paraic A Kenny, John S Condeelis
Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer
Seema Agarwal, Frank B Gertler, Michele Balsamo, John S Condeelis, Robert L Camp, Xiaonan Xue, Juan Lin, Thomas E Rohan, David L Rimm
Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer
Bas Franken, Marco R de Groot, Walter JB Mastboom, Istvan Vermes, Job van der Palen, Arjan GJ Tibbe, Leon WMM Terstappen
Sex hormone changes during weight loss and maintenance in overweight and obese postmenopausal African-American and non-African-American women
Rachael Z Stolzenberg-Solomon, Roni T Falk, Frank Stanczyk, Robert N Hoover, Lawrence J Appel, Jamy D Ard, Bryan C Batch, Janelle Coughlin, Xu Han, Lillian F Lien, Christina M Pinkston, Laura P Svetkey, Hormuzd A Katki
Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland
Mona Shehata, Andrew Teschendorff, Gemma Sharp, Nikola Novcic, I Alasdair Russell, Stefanie Avril, Michael Prater, Peter Eirew, Carlos Caldas, Christine J Watson, John Stingl
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells
Brigitte Bisaro, Maura Montani, Georgia Konstantinidou, Cristina Marchini, Lucia Pietrella, Manuela Iezzi, Mirco Galiè, Francesca Orso, Annalisa Camporeale, Shana M Colombo, Paola Di Stefano, Giusy Tornillo, Maria P Camacho-Leal, Emilia Turco, Daniela Taverna, Sara Cabodi, Augusto Amici, Paola Defilippi
NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro
Matthew J Simmons, Ryan Serra, Nicole Hermance, Michelle A Kelliher
High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients
Nicolas Pernodet, François Hermetet, Pascale Adami, Anne Vejux, Françoise Descotes, Christophe Borg, Marjorie Adams, Jean-René Pallandre, Gabriel Viennet, Frédéric Esnard, Michèle Jouvenot, Gilles Despouy
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
Funda Meric-Bernstam, Huiqin Chen, Argun Akcakanat, Kim-Anh Do, Ana Lluch, Bryan T Hennessy, Gabriel N Hortobagyi, Gordon B Mills, Ana Maria Gonzalez-Angulo